NantHealth said this week that it has launched a fully integrated genomic and transcriptomic analytic engine that can identify mutations such as copy number variants and genomic rearrangements in DNA, RNA, and protein pathways accurately and efficiently.
Arsenal Capital Partners, a New York-based private equity firm, has bought Certara, a provider of model-based drug development and data analytics software and consulting services, from Vector Capital for an undisclosed sum.
NEW YORK (GenomeWeb News) – Private equity firm Arsenal Capital Partners today announced it has bought Certara, a provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical research and development market.
Certara said this week that it is partnering with Thomson Reuters to provide customers of its D360 software solution with access to content contained in Thomson Reuters' Cortellis for Informatics system.
NEW YORK (GenomeWeb News) – Certara said this week that it is working with the Critical Path Institute, C-Path, to create a physiologically-based pharmacokinetic model of the human lung using Certara's Simcyp Population-based simulator software that will be used to test new tuberculosis drugs.